Abstract: A display panel includes a first substrate including a display area, in which a plurality of pixel areas is arranged, and a non-display area around the display area, a second substrate disposed opposite to the first substrate, a light emitting array disposed on the first substrate and including a plurality of light emitting elements corresponding to the plurality of pixel areas, a sealing layer disposed in the non-display area between the first substrate and the second substrate and bonding the first substrate and the second substrate to each other, a vacuum layer sealed by the sealing layer and defined between the light emitting array and the second substrate, and a reflection adjustment layer disposed on the second substrate and absorbing a portion of external light, where the reflection adjustment layer includes a plurality of protrusions protruding toward the light emitting array and exposed to the vacuum layer.

Abstract: The present disclosure relates to a novel PLK1 degradation inducing compound having a structure according to Formula I, a method for preparing the same, and the use thereof. The compounds of the present disclosure exhibit an effect of inducing PLK1 degradation. Therefore, the compounds of the present disclosure may be effectively utilized for preventing or treating PLK1-related diseases.

Abstract: This application relates to a pellicle for extreme ultraviolet lithography and a manufacturing method thereof using the low-temperature direct growth method of multilayer graphene. In one aspect, the method includes forming an etch stopper on a substrate, forming a seed layer on the etch stopper, the seed layer including at least one of amorphous boron, BN, BCN, B4C, or Me-X (Me is at least one of Si, Ti, Mo, or Zr, and X is at least one of B, C, or N). The method may also include forming a metal catalyst layer on the seed layer; forming an amorphous carbon layer on the metal catalyst layer, and directly growing multilayer graphene on the seed layer through interlayer exchange between the metal catalyst layer and the amorphous carbon layer by performing a low-temperature heat treatment at 450° C. to 600° C.

Abstract: This application relates to a pellicle for extreme ultraviolet lithography containing amorphous carbon and a manufacturing method thereof. In one aspect, the pellicle includes a substrate having an opening formed in a central portion, a support layer formed on the substrate to cover the opening, and a pellicle layer formed on the support layer and containing amorphous carbon. The pellicle layer may include a core layer formed on the support layer, and a capping layer formed on the core layer and may further include a buffer layer. At least one of the core layer, the capping layer, or the buffer layer may be an amorphous carbon layer.

Abstract: The present disclosure relates to emulsified oil composition including an oil containing a polyunsaturated fatty acid which is applicable to food, a rosemary extract, and a non-ionic surfactant, wherein the product quality of the food using the oil containing the polyunsaturated fatty acid is maintained during the processing and storage of the food, by preventing the oxidation of the oil containing the polyunsaturated fatty acid to suppress the production of a rancid flavor and an off-flavor.

Abstract: Disclosed is a sample analysis method using a kernel module in a genomic module network. The method includes a step in which an analysis device utilizes gene expression data of a sample to construct a genomic module network based on entropy and a step in which the analysis device analyzes the sample, using a kernel module of a reference genomic module network and a kernel module of the genomic module network of the sample. The kernel module is a module that is lower in entropy by a reference value or greater than the other modules in the corresponding genomic module network. The entropy represents relations between multiple genes on the basis of probabilities of transcriptional states of the multiple genes.

Abstract: A modified conjugated diene-based polymer, a rubber composition including the same, and a method of making the same are disclosed herein. The modified conjugated diene-based polymer has excellent processability and good tensile strength and viscoelasticity. In some embodiments, a modified conjugated diene-based polymer includes a first chain including a repeating unit derived from a conjugated diene-based monomer, a second chain including a repeating unit derived from a compound represented by Formula 1, and a derived unit from an alkoxysilane-based modifier, wherein the first chain and the second chain are coupled by the derived unit from the alkoxysilane-based modifier.

Abstract: This application relates to a method for direct growth of multilayer graphene used as a core layer of a pellicle for extreme ultraviolet lithography. This application also relates to a method for manufacturing the pellicle for extreme ultraviolet lithography by using the multilayer graphene direct growth method. The multilayer graphene direct growth method may include forming few-layer graphene on a silicon nitride substrate, forming a metal catalyst layer on the few-layer graphene, and forming an amorphous carbon layer on the metal catalyst layer. The method may also include directly growing multilayer graphene from the few-layer graphene used as a seed layer by interlayer exchange between the metal catalyst layer and the amorphous carbon layer through heat treatment.

Abstract: Provided is a method of analyzing sample data based on a genomic module network by means of a computer apparatus. The method includes filtering first gene expression data for a normal or tumor tissue, which is the same tissue as a specific tissue, and second gene expression data for a target tissue to be analyzed, which is the same tissue as the specific tissue, on the basis of a specific module among a plurality of genomic modules; and classifying genes into a plurality of new genomic modules on the basis of an entropy determined using the filtered first gene expression data and determining, for genes belonging to at least one of the plurality of new genomic modules, a first degree of variation of the target tissue relative to the normal or tumor tissue in the at least one genomic module using the filtered first gene expression data and the filtered second gene expression data.

Abstract: The present disclosure relates to emulsified oil composition including an oil containing a polyunsaturated fatty acid which is applicable to food, a rosemary extract, and a non-ionic surfactant, wherein the product quality of the food using the oil containing the polyunsaturated fatty acid is maintained during the processing and storage of the food, by preventing the oxidation of the oil containing the polyunsaturated fatty acid to suppress the production of a rancid flavor and an off-flavor.

Abstract: Provided is a method of analyzing sample data based on a genomic module network by means of a computer apparatus. The method includes filtering first gene expression data for a normal or tumor tissue, which is the same tissue as a specific tissue, and second gene expression data for a target tissue to be analyzed, which is the same tissue as the specific tissue, on the basis of a specific module among a plurality of genomic modules; and classifying genes into a plurality of new genomic modules on the basis of an entropy determined using the filtered first gene expression data and determining, for genes belonging to at least one of the plurality of new genomic modules, a first degree of variation of the target tissue relative to the normal or tumor tissue in the at least one genomic module using the filtered first gene expression data and the filtered second gene expression data.

Abstract: A video system for minimizing streaming latency is disclosed. The video system includes an encoder having a data input part receiving external streaming video data, a data conversion part converting the external streaming video data to output converted video data, a first buffer receiving the converted video data, a data measurement part measuring size of the converted video data and conversion time spent for converting the streaming data, and a latency determination part comparing the size and the conversion time, respectively, to a reference size and a reference time to determine latency; and a decoder having a second buffer receiving the converted video data from the first buffer. The latency determination part transmitting the determined result to the data input part and the data input part outputs a latest streaming video data in response to determination that the first buffer or second buffer will be in underflow.

Abstract: A photograph generation apparatus that controls a light source and corrects a picture using an illuminance sensor and a transparent liquid crystal, the photograph generation apparatus includes: a camera part configured to take a photographed picture of a user using the photograph generation apparatus; a lighting part configured to provide lighting for an object to be photographed using the photograph generation apparatus; an illuminance sensor part configured to measure an illuminance within a predetermined range of the photograph generation apparatus to use the measured illuminance in controlling the lighting of the lighting part; and a transparent liquid crystal panel mounted at a front surface of the camera part and configured to control an amount of a light source radiated to the camera part when the picture is being taken.

Abstract: The present disclosure relates to a pharmaceutical composition or a food composition which has excellent activity of stimulating enteroendocrine cells while being safe with few side effects. The composition contains one or more of an Oldenlandia brachypoda extract, a Spergularia marina extract, a Disporum smilacinum extract, a Persicaria posumbu extract and a Geum aleppicum extract as an active ingredient. The composition of the present disclosure can be usefully used as a pharmaceutical composition or a food composition for preventing, improving or treating diabetes mellitus, improving or treating heart diseases, improving or treating arteriosclerosis, improving or treating digestive disorders and malabsorption, preventing or treating obesity or suppressing appetite, protecting nerves, treating or improving liver diseases, and so forth.

Abstract: A cache memory device is provided. The cache memory device includes a memory including a first cache memory region and a second cache memory region, and a control block. The control block determines a type of data to be received. The control block also performs at least one of transmitting a head of received data to a first cache memory region, transmitting a body of the received data to a second cache memory region and transmitting a tail of the received data to the first cache memory region based on the type of the data to be received.

Abstract: A pharmaceutical composition for preventing and treating endocrine disrupting chemicals-induced diseases and a treating method using the same. Since the composition has an effect of decreasing lipid accumulation caused by endocrine disrupting chemicals, for example, persistent organic pollutants (POPs) including polychlorinated biphenyl and the like and can improve insulin resistance caused by the POPs through reduction of insulin receptor substrate 1 (IR1), the composition can be helpfully used for treating diseases including obesity, insulin resistance, and the like caused by the endocrine disrupting chemicals. Further, according to the present disclosure, the composition has an effect of excreting the endocrine disrupting chemicals.

Abstract: A photograph generation apparatus that controls a light source and corrects a picture using an illuminance sensor and a transparent liquid crystal, the photograph generation apparatus includes: a camera part configured to take a photographed picture of a user using the photograph generation apparatus; a lighting part configured to provide lighting for an object to be photographed using the photograph generation apparatus; an illuminance sensor part configured to measure an illuminance within a predetermined range of the photograph generation apparatus to use the measured illuminance in controlling the lighting of the lighting part; and a transparent liquid crystal panel mounted at a front surface of the camera part and configured to control an amount of a light source radiated to the camera part when the picture is being taken.

Abstract: A pharmaceutical composition for preventing and treating endocrine disrupting chemicals-induced diseases and a treating method using the same. Since the composition has an effect of decreasing lipid accumulation caused by endocrine disrupting chemicals, for example, persistent organic pollutants (POPs) including polychlorinated biphenyl and the like and can improve insulin resistance caused by the POPs through reduction of insulin receptor substrate 1 (IR1), the composition can be helpfully used for treating diseases including obesity, insulin resistance, and the like caused by the endocrine disrupting chemicals. Further, according to the present disclosure, the composition has an effect of excreting the endocrine disrupting chemicals.

Abstract: The present invention relates to a fiducial marker comprising barium sulfate (BaSO4), a solvent, and a polyethylene glycol-poly(aminourethaneurea) multi-block copolymer, as active ingredients. The fiducial marker of the present invention has an effect of significantly remedying disadvantages of image distortion and dose distortion, which are involved in the gold inner marker used in the conventional art. The fiducial marker of the present invention has very limited in vivo mobility, and thus the fiducial marker is maintained at the position at which it has been initially injected. Since the fiducial marker of the present invention is maintained in a sol or liquid state before in vivo injection, and transited into a gel or solid phase after in vivo injection, the injectability of the fiducial marker by an injector syringe is favorable, and the state of the fiducial marker can be controlled into a phase suitable to each site of the therapeutic target.

Abstract: A thermoplastic resin composition includes a thermoplastic resin; a pearlescent pigment; and a pigment that is not the same as the pearlescent pigment, wherein the pearlescent pigment and pigment have da and db satisfying da<15 and db<15 in an L*a*b* colorimetric system, respectively.